Michael A Howard1, Mark Sisco1, Katharine Yao2, David J Winchester2, Ermilo Barrera2, Jeremy Warner1, Jennifer Jaffe2, Peter Hulick3, Kristine Kuchta4, Andrea L Pusic5, Stephen F Sener6. 1. Division of Plastic Surgery, NorthShore University Health System, Evanston, Illinois. 2. Department of Surgery, NorthShore University Health System, Evanston, Illinois. 3. Division of Medical Genetics NorthShore, Evanston, Illinois. 4. Center for Biomedical Research Informatics, NorthShore University Health System, Evanston, Illinois. 5. Division of Plastic and Reconstructive Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York. 6. Department of Surgery, Keck School of Medicine University of Southern California, Los Angeles, California.
Abstract
BACKGROUND AND OBJECTIVES: The authors sought to study patient-reported outcomes following nipple-sparing mastectomy (NSM). METHODS: From 2008 to 2011, the BREAST-Q was administered to women undergoing NSM surgery for cancer treatment or risk-reduction prior to surgery and at 2 years after completion of reconstruction. The change in score over time and the impact of surgical indication, complication occurrence, and laterality on scores were analyzed. RESULTS: The BREAST-Q was prospectively administered to 39 women undergoing NSM for cancer treatment (n = 17) or risk-reduction (RR) (n = 22). At 2 years after operation, median overall satisfaction with breasts was 75 (IQR = 67,100). There were significant postoperative increases in scores for overall satisfaction with breasts (+8, P = 0.021) and psychosocial well-being (+14, P = 0.003). Postoperatively, RR patients had significantly higher scores for psychosocial wellness, physical impact (chest), and overall satisfaction with outcome compared to cancer treatment patients (P < 0.05). Also, increase from preoperative to postoperative psychosocial wellness was higher in the RR compared to cancer treatment patients (+17 vs. +1, P = 0.043). Complication occurrence did not significantly impact postoperative scores. CONCLUSIONS: Following NSM for cancer treatment or RR, patients demonstrated high levels of satisfaction and quality of life as measured by BREAST-Q. Satisfaction level increased 2 years following operation. J. Surg. Oncol. 2016;114:416-422.
BACKGROUND AND OBJECTIVES: The authors sought to study patient-reported outcomes following nipple-sparing mastectomy (NSM). METHODS: From 2008 to 2011, the BREAST-Q was administered to women undergoing NSM surgery for cancer treatment or risk-reduction prior to surgery and at 2 years after completion of reconstruction. The change in score over time and the impact of surgical indication, complication occurrence, and laterality on scores were analyzed. RESULTS: The BREAST-Q was prospectively administered to 39 women undergoing NSM for cancer treatment (n = 17) or risk-reduction (RR) (n = 22). At 2 years after operation, median overall satisfaction with breasts was 75 (IQR = 67,100). There were significant postoperative increases in scores for overall satisfaction with breasts (+8, P = 0.021) and psychosocial well-being (+14, P = 0.003). Postoperatively, RR patients had significantly higher scores for psychosocial wellness, physical impact (chest), and overall satisfaction with outcome compared to cancer treatment patients (P < 0.05). Also, increase from preoperative to postoperative psychosocial wellness was higher in the RR compared to cancer treatment patients (+17 vs. +1, P = 0.043). Complication occurrence did not significantly impact postoperative scores. CONCLUSIONS: Following NSM for cancer treatment or RR, patients demonstrated high levels of satisfaction and quality of life as measured by BREAST-Q. Satisfaction level increased 2 years following operation. J. Surg. Oncol. 2016;114:416-422.
Authors: Virgilio Sacchini; José A Pinotti; Alfredo C S D Barros; Alberto Luini; Alfonso Pluchinotta; Marianne Pinotti; Marcelo G Boratto; Marco D Ricci; Carlos A Ruiz; Antonio C Nisida; Paolo Veronesi; Jean Petit; Paolo Arnone; Fabio Bassi; Joseph J Disa; Carlos A Garcia-Etienne; Patrick I Borgen Journal: J Am Coll Surg Date: 2006-09-11 Impact factor: 6.113
Authors: Kelly A Metcalfe; Tulin D Cil; John L Semple; Lucy Dong Xuan Li; Shaghayegh Bagher; Toni Zhong; Sophia Virani; Steven Narod; Tuya Pal Journal: Ann Surg Oncol Date: 2015-07-25 Impact factor: 5.344
Authors: V L M Rundell; R T Beck; C E Wang; K A Gutowski; M Sisco; G Fenner; M A Howard Journal: J Plast Reconstr Aesthet Surg Date: 2014-05-28 Impact factor: 2.740
Authors: Lucy De La Cruz; Alison M Moody; Erryn E Tappy; Stephanie A Blankenship; Eric M Hecht Journal: Ann Surg Oncol Date: 2015-08-05 Impact factor: 5.344
Authors: Starr Koslow; Lindsay A Pharmer; Amie M Scott; Michelle Stempel; Monica Morrow; Andrea L Pusic; Tari A King Journal: Ann Surg Oncol Date: 2013-05-30 Impact factor: 5.344
Authors: Elizabeth B Odom; Rajiv P Parikh; Grace Um; Simone W Kantola; Amy E Cyr; Julie A Margenthaler; Marissa M Tenenbaum; Terence M Myckatyn Journal: Plast Reconstr Surg Date: 2018-07 Impact factor: 4.730
Authors: M G Valero; T-A Moo; S Muhsen; E C Zabor; M Stempel; A Pusic; M L Gemignani; M Morrow; V Sacchini Journal: Br J Surg Date: 2020-05-20 Impact factor: 6.939
Authors: Bridget N Kelly; Heather R Faulkner; Barbara L Smith; Jenna E Korotkin; Conor R Lanahan; Carson Brown; Michele A Gadd; Michelle C Specht; Kevin S Hughes; T Salewa Oseni; Amy S Colwell; Suzanne B Coopey Journal: Ann Surg Oncol Date: 2021-09-08 Impact factor: 5.344
Authors: Maria Herrera de la Muela; Enrique García López; Laura Frías Aldeguer; Paloma Gómez-Campelo Journal: BMJ Open Date: 2017-12-19 Impact factor: 2.692
Authors: Vera L Negenborn; Rieky E G Dikmans; Mark-Bram Bouman; Janneke A Wilschut; Margriet G Mullender; C Andrew Salzberg Journal: Plast Reconstr Surg Glob Open Date: 2018-02-08